Sodium Hydroxide → HCID 10370621, compound
Reaction equation
[NH2:1][C:2]1[N:7]([CH2:8][CH2:9][CH2:10][CH3:11])[C:6](=[O:12])[N:5]([CH2:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=2[F:20])[C:4](=[O:21])[C:3]=1[NH:22][C:23](=O)[CH2:24][C:25]1[CH:30]=[CH:29][C:28]([S:31](=[O:40])(=[O:39])[NH:32][C:33]2[CH:38]=[CH:37][CH:36]=[CH:35][N:34]=2)=[CH:27][CH:26]=1.[OH-].[Na+]>CO>[CH2:8]([N:7]1[C:2]2[N:1]=[C:23]([CH2:24][C:25]3[CH:26]=[CH:27][C:28]([S:31]([NH:32][C:33]4[CH:38]=[CH:37][CH:36]=[CH:35][N:34]=4)(=[O:39])=[O:40])=[CH:29][CH:30]=3)[NH:22][C:3]=2[C:4](=[O:21])[N:5]([CH2:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=2[F:20])[C:6]1=[O:12])[CH2:9][CH2:10][CH3:11]Participants
Procedure
A solution of crude N-[6-amino-1-butyl-3-(2-fluoro-benzyl)-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-2-[4-(pyridin-2-ylsulfamoyl)-phenyl]-acetamide (50 mg, 0.86 mmol) in methanol (5 mL) was treated with a 10% w/v aqueous sodium hydroxide solution (0.1 mL, 0.25 mmol). The resulting solution was heated to reflux for until all of the starting material had been consumed. At this time, the reaction mixture was concentrated in vacuo. Flash chromatography (Merck Silica gel 60, 230–400 mesh, 5/95 methanol/methylene chloride) followed by trituration with cold methanol afforded 4-[3-butyl-1-(2-fluoro-benzyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]-N-pyridin-2-yl-benzenesulfonamide (14.7 mg, 26% from [4-(pyridin-2-ylsulfamoyl)-phenyl]-acetic acid) as a colorless solid; 1H NMR(DMSO-d6, 300 MHz) δH 13.50 (broad s, 1H), 7.90 (broad s, 1H), 7.74 (d, J=8.1 Hz, 2H), 7.63 (t, J=7.3 Hz, 1H), 7.37 (d, J=7.7 Hz, 2H), 7.30–6.95 (m, 5H), 6.77 (broad s, 1H), 5.02 (s, 2H), 4.06 (s, 2H), 3.87 (t, J=7.1 Hz, 2H), 1.54 (t, J=7.0 Hz, 2H), 1.17 (q, J=7.5 Hz, 2H), 0.77 (t, J=7.3 Hz, 3H); FAB-HRMS m/e calculated for C28H27FN6O4S (M+H)+ 563.1877, found 563.1860.
Workup
- temperatureThe resulting solution was heated
- temperatureto reflux for until all of the starting material
- customhad been consumed
- concentrationAt this time, the reaction mixture was concentrated in vacuo
Sources & evidence
- ORD record
- ord-df9b02bc56eb47508ef0915cb6771eff
- Source dataset
- uspto-grants-2006_12
- Patent number
- US07148229B2
Reaction notes
Loading…